Blood, Blood-Forming Organs, and the Immune Mechanism

Published on 02/03/2015 by admin

Filed under Basic Science

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 6805 times

Blood, Blood-Forming Organs, and the Immune Mechanism

ICD-10-CM Examples from Tabular

D72.82 Elevated white blood cell count

Excludes1 eosinophilia (D72.1)

D72.820. Lymphocytosis (symptomatic)

D72.821. Monocytosis (symptomatic)

    Excludes1 infectious mononucleosis (B27.-)

D72.822. Plasmacytosis

D72.823. Leukemoid reaction

D72.824. Basophilia

D72.825. Bandemia

Excludes1 confirmed infection—code to infection leukemia (C91.-, C92.-, C93.-, C94.-, C95.-)

D72.828. Other elevated white blood cell count

D72.829. Elevated white blood cell count, unspecified

D72.89. Other specified disorders of white blood cells

Functions of the Blood and Immune Systems

Homeostasis, or a “steady state,” is a continual balancing act of the body systems to provide an internal environment that is compatible with life. The two liquid tissues of the body, the blood and lymph, have separate but interrelated functions in maintaining this balance. They combine with a third system, the immune system, to protect the body against pathogens that could threaten the organism’s viability.

The blood is responsible for the following:

The lymph system is responsible for the following:

The immune system is responsible for the following:

Figure 8-1 is a Venn diagram of the interrelationship among the three systems, with the shared goals of homeostasis and protection at the intersection of the three circles.

Anatomy and Physiology

The hematic and lymphatic systems flow through separate yet interconnected and interdependent channels. Both are systems composed of vessels and the liquids that flow through them. The immune system, a very complex set of levels of protection for the body, includes blood and lymph cells.

Figure 8-2 shows the relationship of the lymphatic vessels to the circulatory system. Note the close relationship between the distribution of the lymphatic vessels and the venous blood vessels. Tissue fluid is drained by the lymphatic capillaries and is transported by a series of larger lymphatic vessels toward the heart.

The organs in the lymphatic system are the spleen, the thymus gland, the tonsils, the appendix, and Peyer’s patches. The spleen is located in the upper left quadrant and serves to filter, store, and produce blood cells; remove red blood cells (RBCs); and activate B lymphocytes. The thymus gland is located in the mediastinum and is instrumental in the development of T lymphocytes (T cells). The tonsils are lymphatic tissue (lingual, pharyngeal, and palatine) that helps protect the entrance to the respiratory and digestive systems. The vermiform appendix and Peyer’s patches are lymphoid tissue in the intestines.

The clearest path to understanding the interconnected roles of these three systems is to look at the hematic system first.

Hematic System

The hematic system is composed of blood and the vessels that carry the blood throughout the body. The formation of blood, hematopoiesis, begins in the bone marrow with a single type of cell, a multipotential (pluripotent) hematopoietic stem cell (HSC), or hemocytoblast. This cell divides into cells that mature in lymphatic tissue (band T lymphocytes) and cells that mature in the bone marrow. Refer to Figure 8-3 to follow the development from the stem cell to specialized mature blood cells.

Whole blood is composed of a solid portion that consists of formed elements, or cells, and a liquid portion called plasma. Blood cells make up 45% of the total blood volume, and plasma makes up the other 55% (Fig. 8-4).

< ?xml:namespace prefix = "mml" />(whole) blood=blood cells (45%)+plasma (55%)

image

The solid portion of blood is composed of three different types of cells:

In a milliliter of blood, there are 4.2 million to 5.8 million RBCs, 250,000 to 400,000 platelets, and 5000 to 9000 WBCs. These cells together account for approximately 8% of body volume. Converted to more familiar liquid measure, there are about 10.5 pints (5 liters) of blood in a 150-lb (68-kg) person.

Components of Blood

Erythrocytes (Red Blood Cells)

The erythrocytes (which are normally present in the millions) have the important function of transporting O2 and CO2 throughout the body (Fig. 8-5). The vehicle for this transportation is a protein-iron pigment called hemoglobin. When combined with oxygen, it is termed oxyhemoglobin.

The formation of RBCs in the red bone marrow, the blood-producing cavities found in many bones, is stimulated by a hormone from the kidneys called erythropoietin. RBCs have a life span of approximately 120 days, after which they decompose into hemosiderin, an iron pigment resulting from hemolysis, and bilirubin. The iron is stored in the liver to be recycled into new RBCs, and the bile pigments are excreted via the liver.

Abnormal RBCs can be named by their morphology, the study of shape or form. RBCs normally have a biconcave, disclike shape and are anuclear (without a nucleus). (Although the center is depressed, there is not an actual hole.) Those that are shaped differently often have difficulty in carrying out their function.

For example, sickle cell anemia is a hereditary condition characterized by erythrocytes (RBCs) that are abnormally shaped. They resemble a crescent or sickle. An abnormal hemoglobin found inside these erythrocytes causes sickle-cell anemia in a number of Africans and African Americans.

Leukocytes (White Blood Cells)

Although there are fewer leukocytes (thousands, not millions), there are different types with different functions. In general, WBCs protect the body from invasion by pathogens. The different types of cells provide this defense in a number of different ways. There are two main types of WBCs: granulocytes and agranulocytes.

Granulocytes (Polymorphonucleocytes)

Named for their appearance, granulocytes, also called polymorphonucleocytes (PMNs, or polys) are white blood cells that have small grains within the cytoplasm and multilobed nuclei. These names are used interchangeably.

There are three types of granulocytes, each with its own function. Each of them is named for the type of dye that it attracts.

1. Eosinophils (eosins) are cells that absorb an acidic dye, which causes them to appear reddish. An increase in eosinophils is a response to a need for their function in defending the body against allergens and parasites.

2. Neutrophils (neuts), the most numerous WBCs, are cells that do not absorb either an acidic or a basic dye and consequently are a purplish color. They are also called phagocytes because they specialize in phagocytosis and generally combat bacteria in pyogenic infections. This means that these cells are drawn to the site of a pathogenic “invasion,” where they consume the enemy and remove the debris resulting from the battle. Because the nucleus in immature neutrophils has a long “bandlike” shape, these cells are often referred to as band cells. They are also called stabs; the name is from the German word for rods because of their rodlike appearance. As the cells continue to mature, the bands divide, and the adult cells are renamed segs because now the nuclei are divided into clumps (segmented).

3. Basophils (basos) are cells that absorb a basic (or alkaline) dye and stain a bluish color. Especially effective in combating parasites, they release histamine (a substance that initiates an inflammatory response) and heparin (an anticoagulant), both of which are instrumental in healing damaged tissue.

Agranulocytes (Mononuclear Leukocytes)

Agranulocytes are white blood cells named for their lack of granules. The alternative name mononuclear leukocytes is so given because they have one nucleus. The two names are used interchangeably. Although these cells originate in the bone marrow, they mature after entering the lymphatic system. There are two types of these WBCs:

Thrombocytes (Platelets)

Platelets (also known as thrombocytes or plats) have a round or oval shape and are so named because they look like small plates. Platelets aid in coagulation, the process of changing a liquid to a solid. When blood cells escape their normal vessels, they agglutinate, or clump together, by the following process: First, they release factor X (formerly called thrombokinase), which, in the presence of calcium, reacts with the blood protein prothrombin to form thrombin. Thrombin then converts another blood protein, fibrinogen, to fibrin, which eventually forms a meshlike fibrin clot (blood clot), achieving hemostasis (control of blood flow; that is, stopping the bleeding). See Figure 8-6 for a visual explanation of the clotting process.

Plasma

Plasma, the liquid portion of blood, is composed of the following:

Serum (pl. sera) is plasma minus the clotting proteins. Serology is the branch of laboratory medicine that studies blood serum for evidence of infection by evaluating antigen-antibody reactions in vitro.

Serum=Plasma (Prothrombin+Fibrinogen)

image

image

B. Match the following suffixes with their meanings.

Decode the terms.

Blood Groups

Human blood is divided into four major different types: A, B, AB, and O. See Figure 8-7 for a table of blood types, agglutinogens, and agglutinins. The differences are due to antigens present on the surface of the red blood cells. Antigens are substances that produce an immune reaction by their nature of being perceived as foreign to the body. In response, the body produces substances called antibodies that nullify or neutralize the antigens. In blood, these antigens are called agglutinogens because their presence can cause the blood to clump. The antibody is termed an agglutinin. For example, type A blood has A antigen, type B has B antigen, type AB has both A and B antigens, and type O has neither A nor B antigens. If an individual with type A blood is transfused with type B blood, the A antigens will form anti-B antibodies because they perceive B blood as being foreign. Following the logic of each of these antigen-antibody reactions, an individual with type AB blood is a universal recipient, and an individual with type O blood is a universal donor.

Another antigen, the Rh factor, is important in pregnancy because a mismatch between the fetus and the mother can cause erythroblastosis fetalis, or hemolytic disease of the newborn (HDN) (see Fig. 7-10). In this disorder, a mother with a negative Rh factor will develop antibodies to an Rh+ fetus during the first pregnancy. If another pregnancy occurs with an Rh+ fetus, the antibodies will destroy the fetal blood cells.

Immune System

The immune system is composed of organs, tissues, cells, and chemical messengers that interact to protect the body from external invaders and its own internally altered cells. The chemical messengers are cytokines, which are secreted by cells of the immune system that direct immune cellular interactions. Lymphocytes (leukocytes that are categorized as either B cells or T cells) secrete lymphokines. Monocytes and macrophages secrete monokines. Interleukins are a type of cytokine that sends messages among leukocytes to direct protective action.

The best way to understand this system is through the body’s various levels of defense. The goal of pathogens is to breach these levels to enter the body, reproduce, and, subsequently, exploit healthy tissue, causing harm. The immune system’s task is to stop them.

Figure 8-8 illustrates the levels of defense. The two outside circles represent nonspecific immunity and its two levels of defense. The inner circle represents the various mechanisms of specific immunity, which can be natural (genetic) or acquired in four different ways. Most pathogens can be contained by the first two lines of nonspecific defense. However, some pathogens deserve a “special” means of protection, which is discussed in the section titled “Specific Immunity.”

Nonspecific Immunity

This term refers to the various ways that the body protects itself from many types of pathogens, without having to “recognize” them. The first line of defense in nonspecific immunity (the outermost layer) consists of the following methods of protection:

The second line of defense in nonspecific immunity comes into play if the pathogens make it past the first line. Defensive measures include certain processes, proteins, and specialized cells.

Defensive processes include the following:

• Phagocytosis: Phagocytosis is the process of cells “eating” and destroying microorganisms. Pathogens that make it past the first line of defense and enter into the bloodstream may be consumed by neutrophils and monocytes.

• Inflammation: Acquiring its name from its properties, inflammation is a protective response to irritation or injury. The characteristics (heat, swelling, redness, and pain) arise in response to an immediate vasoconstriction, followed by an increase in vascular permeability. These provide a good environment for healing. If caused by a pathogen, the inflammation is called an infection.

• Pyrexia: Pyrexia is the medical term for fever. When infection is present, fever may serve a protective function by increasing the action of phagocytes and decreasing the viability of certain pathogens.

The protective proteins are part of the second line of defense. These include interferons, which get their name from their ability to “interfere” with viral replication and limit a virus’s ability to damage the body. The complement proteins, a second protein type, exist as inactive forms in blood circulation that become activated in the presence of bacteria, enabling them to lyse (destroy) the organisms.

Finally the last of the “team” in the second line of defense are the natural killer (NK) cells. This special kind of lymphocyte acts nonspecifically to kill cells that have been infected by certain viruses and cancer cells.

Specific Immunity

Specific immunity may be either genetic—an inherited ability to resist certain diseases because of one’s species, race, sex, or individual genetics—or acquired. Specific immunity depends on the body’s ability to identify a pathogen and prepare a specific response (antibody) to only that invader (antigen). Antibodies are also referred to as immunoglobulins (Ig). The acquired form can be further divided into natural and artificial forms, which in turn can each be either active or passive. After the specific immune process is described, each of the four types is discussed.

Specific immunity depends on the agranulocytes (lymphocytes and monocytes) for its function. The monocytes metamorphose into macrophages, which dispose of foreign substances. The lymphocytes differentiate into either T lymphocytes (they mature in the thymus) or B lymphocytes (they mature in the bone marrow or fetal liver). Although both types of lymphocytes take part in specific immunity, they do so in different ways.

The T cells neutralize their enemies through a process of cell-mediated immunity. This means that they attack antigens directly. They are effective against fungi, cancer cells, protozoa, and, unfortunately, organ transplants. B cells use a process of humoral immunity (also called antibody-mediated immunity). This means that they secrete antibodies to “poison” their enemies, either during the attack (plasma B cells) or in subsequent attacks (memory B cells).

Types of Acquired Immunity

Acquired immunity is categorized as active or passive and then is further subcategorized as natural or artificial. All describe ways that the body has acquired antibodies to specific diseases.

Active acquired immunity can take either of the following two forms:

Passive acquired immunity can take either of the following two forms:

image

Combining Forms for the Anatomy and Physiology of Blood and the Immune System

Meaning Combining Form
appendix append/o, appendic/o
base bas/o
blood hem/o, hemat/o
bone marrow myel/o
cell cyt/o
clotting, clot thromb/o
clumping agglutin/o
disease path/o
eat, swallow phag/o
fever, fire pyr/o
fiber fibr/o
fibrous substance fibrin/o
liquid humor/o
little grain granul/o
lymph lymph/o, lymphat/o
nucleus nucle/o
oxygen ox/i, ox/o
plasma plasm/a, plasm/o
red erythr/o
rosy-colored eosin/o
safety, protection immun/o
same home/o
serum ser/o
shape morph/o
spleen splen/o
thymus thym/o
tonsil tonsill/o
white leuk/o

Prefixes for the Anatomy and Physiology of the Blood and Immune Systems

Prefix Meaning
a- without
anti- against
inter- between
mono- one
oxy- oxygen
poly- many
pro- before

Suffixes for the Anatomy and Physiology of the Blood and Immune Systems

Suffix Meaning
-cyte cell
-exia condition
-gen producing
-globin protein substance
-in substance
-kine movement
-leukin white substance
-lysis breaking down
-osis abnormal condition
-phil attraction
-poiesis formation
-poietin forming substance
-siderin iron substance
-stasis controlling, stopping
-thrombin clotting substance

Pathology

Terms Related to Nutritional Anemias (D5Ø-D53)

Term Word Origin Definition
B12 deficiency anemia   Insufficient blood levels of cobalamin, also called vitamin B12, which is essential for red blood cell maturation. Condition may be caused by inadequate dietary intake, as in some extreme vegetarian diets, or it may result from absence of intrinsic factor, a substance in the GI system essential to vitamin B12 absorption.
folate deficiency anemia   Anemia as a result of a lack of folate from dietary, drug-induced, congenital, or other causes.
pernicious anemia an- no, not, without
-emia blood condition
Progressive anemia that results from a lack of intrinsic factor essential for the absorption of vitamin B12.
sideropenia sider/o iron
-penia condition of deficiency
Condition of having reduced numbers of RBCs because of chronic blood loss, inadequate iron intake, or unspecified causes. A type of iron deficiency anemia.

Terms Related to Hemolytic Anemias (D55-D59)

Term Word Origin Definition
autoimmune acquired hemolytic anemia auto- self
immune safety, protection
hem/o blood
-lytic pertaining to destruction
an- no, not
-emia blood condition
Anemia caused by the body’s destruction of its own RBCs by serum antibodies.
glucose-6-phosphate-dehydrogenase (G6PD)   An inherited enzyme deficiency that causes hemolytic anemia.
hemoglobinopathy hem/o blood
globin/o protein
-pathy disease process
A general term for genetic defects of hemoglobin.
hemolytic anemia hem/o blood
-lytic pertaining to destruction
A group of anemias caused by destruction of red blood cells.
hereditary spherocytosis spher/o sphere, globe
-cytosis condition of abnormal increase in cells
Condition in which red blood cells have a round shape (instead of biconcave disc-shape) because of a fragile membrane.
nonautoimmune acquired hemolytic anemia non- not
hem/o blood
-lytic pertaining to destruction
an- no, not
-emia blood condition
Anemia that may be drug induced or may be caused by an infectious disease, in which the RBCs are destroyed.
sickle-cell disorders   Sickle cell trait is a condition where an individual has one gene that is for normal hemoglobin and one for sickle hemoglobin. Those who have the trait do not exhibit symptoms of sickle cell disease.
Sickle cell anemia is an inherited anemia characterized by crescent-shaped RBCs. This abnormality in morphology causes RBCs to block small-diameter capillaries, thereby decreasing the oxygen supply to the cells (Fig. 8-9). A sickle cell crisis is an acute, painful exacerbation of sickle cell anemia.
thalassemia thalass/o sea
-emia blood condition
Group of inherited disorders of people of Mediterranean, African, and Southeast Asian descent, in which the anemia is the result of a decrease in the synthesis of hemoglobin, resulting in decreased production and increased destruction of RBCs.

Terms Related to Aplastic and Other Anemias and Other Bone Marrow Failure Syndromes (D6Ø-D64)

Term Word Origin Definition
acute posthemorrhagic anemia post- after
hem/o blood
-rrhagic pertaining to bursting forth
an- no, not
-emia blood condition
RBC deficiency caused by blood loss.
aplastic anemia a- no, not, without
plast/o formation
-ic pertaining to
an- no, not, without
-emia blood condition
Suppression of bone marrow function leading to a reduction in RBC production. Although causes of this often fatal type of anemia may be hepatitis, radiation, or cytotoxic agents, most causes are idiopathic. Also called hypoplastic anemia (Fig. 8-10).
erythroblastopenia erythr/o red
blast/o embryonic, immature
-penia condition of deficiency
Deficiency of immature red blood cells. Significant in that they indicate a future lack of mature blood cells.
myelophthisis myel/o bone marrow
-phthisis wasting
Wasting of bone marrow, usually with replacement by cancer cells.
pancytopenia pan- all
cyt/o cell
-penia condition of deficiency
Deficiency of all blood cells caused by dysfunctional stem cells (Fig. 8-11).

image

Build the terms.

Terms Related to Coagulation Defects, Purpura, and Other Hemorrhagic Conditions (D65-D69)

Term Word Origin Definition
disseminated intravascular coagulopathy (DIC) intra- within
vascul/o vessel
-ar pertaining to
coagul/o clotting
-pathy disease process
A disorder of clotting mechanisms that results in bleeding at scattered sites in the body.
hemophilia hem/o blood
-philia condition of attraction
Group of inherited bleeding disorders characterized by a deficiency of one of the factors (factor VIII) necessary for the coagulation of blood (Fig. 8-12).
purpura purpur/o purple
-a noun ending
Bleeding disorder characterized by hemorrhage into the tissues (Fig. 8-13).
thrombocytopenia thromb/o clot, clotting
cyt/o cell
-penia condition of deficiency
Deficiency of platelets that causes an inability of the blood to clot. The most common cause of bleeding disorders.
thrombophilia thromb/o clot
philia condition of attraction
An increase in the body’s tendency to form clots.

Terms Related to Other Disorders of Blood and Blood-Forming Organs (D7Ø-D77)

Term Word Origin Meaning
asplenia a- without
splen/o spleen
-ia condition
Absence of the spleen, either congenital or acquired due to surgical removal.
bandemia band/o bands
-emia blood condition
An increase in the number of immature neutrophils (band cells) in the blood. Increases of band cells may indicate infection.
basophilia bas/o base
-philia condition of attraction
Excessive basophils in the blood.
eosinophilia eosin/o rosy-colored
-philia condition of attraction
An increase in the number of eosinophils in the blood.
erythrocytosis erythr/o red
-cytosis condition of abnormal increase of cells
An excessive number of red blood cells in the blood.
hypersplenism hyper- excessive
splen/o spleen
-ism condition
Increased function of the spleen, resulting in hemolysis (Fig. 8-14).
leukocytosis leuk/o white
-cytosis condition of abnormal increase in cells
Abnormal increase in WBCs. Abnormal increases in each type of granulocyte are termed eosinophilia, basophilia, and neutrophilia, where the suffix -philia denotes a slight increase. Abnormal increases in the number of each type of agranulocyte are termed lymphocytosis and monocytosis.
leukopenia leuk/o white
-penia condition of deficiency
Abnormal decrease in WBCs. Specific deficiencies are termed neutropenia, eosinopenia, monocytopenia, and lymphocytopenia. Also called leukocytopenia.
lymphocytopenia lymph/o lymph
cyt/o cell
-penia condition of deficiency
Deficiency of lymphocytes caused by infectious mononucleosis, malignancy, nutritional deficiency, or a hematological disorder.
methemoglobinemia met(a)- change
hem/o blood
globin/o protein
-emia blood condition
Abnormal condition in which red blood cells are unable to carry hemoglobin. May be hereditary or acquired.
monocytosis mono- one
cytosis abnormal increase of cells
Excessive monocytes in the blood.
myelofibrosis myel/o bone marrow
fibr/o fiber
-osis abnormal condition
Abnormal condition of fibrous tissue development in the bone marrow due to a chromosomal abnormality (Fig. 8-15).
neutropenia neutr/o neutral
-penia condition of deficiency
Abnormal decrease in neutrophils due to disease process. Formerly called agranulocytosis.
plasmacytosis plasm/a plasma
-cytosis abnormal increase of cells
Excessive plasma cells in the blood.
splenitis splen/o spleen
-itis inflammation
Inflammation of the spleen.

Terms Related to Systemic Infections of the Blood

Term Word Origin Definition
septicemia septic/o infection
-emia blood condition
Systemic infection with pathological microbes in the blood as the result of an infection that is spread from elsewhere in the body. The term sepsis means infection.
septic shock sept/o infection
-ic pertaining to
Inadequate blood flow to the body caused by an overwhelming infection and resultant low blood pressure. Organs fail and death may occur.
systemic inflammatory response syndrome (SIRS)   Type of septic shock, SIRS is an inflammatory state affecting the whole body. SIRS can be caused by trauma, ischemia, or inflammation.

image

Decode the terms.

Terms Related to Certain Disorders Involving the Immune Mechanism (D8Ø-D89)

Term Word Origin Definition
autoimmune lymphoproliferative syndrome (ALPS) auto- self
immun/o safety, protection
syn- together
drome run
Inherited disorder of the immune system with unusually high numbers of lymphocytes that accumulate in the lymph nodes, liver, and spleen.
graft-versus-host disease (GVHD)   Disorder occurring when donated tissue cells attack the cells of the recipient.
hypogammaglobulinemia hypo- deficiency
gamma
globulin/o protein
-emia blood condition
A lack of antibodies (immunoglobulin G) in the blood.
sarcoidosis sarc/o flesh
-oid like
-osis abnormal condition
An inflammatory disorder in which small, fleshlike tumors develop throughout the body.

Terms Related to Other Immune Disorders

Term Word Origin Definition
acquired immunodeficiency syndrome (AIDS) immun/o safety, protection Syndrome caused by the human immunodeficiency virus (HIV) and transmitted through body fluids. Figure 8-16 demonstrates the life cycle of HIV.
autoimmune disease auto- self
immun/o safety, protection
Condition in which a person’s T cells attack his/her own cells, causing extensive tissue damage and organ dysfunction. Examples of resultant autoimmune diseases include myasthenia gravis, rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.

image

Terms Related to Benign Neoplasms

Term Word Origin Definition
myelodysplastic syndrome myel/o bone marrow
dys- abnormal
-plastic pertaining to forming
Group of disorders that result from a defect in the bone marrow. Also referred to as preleukemia.
polycythemia vera poly- many, much
cyt/o cell
-(h)emia blood condition
vera true
Condition in which the bone marrow produces an excessive number of blood cells.
thymoma thym/o thymus gland
-oma tumor, mass
Noncancerous tumor of epithelial origin that is often associated with myasthenia gravis.

Terms Related to Malignant Neoplasms

Term Word Origin Definition
acute lymphocytic leukemia (ALL) lymph/o lymph
cyt/o cell
-ic pertaining to
leuk/o white
-emia blood condition
Also termed acute lymphoblastic leukemia, this cancer is characterized by the uncontrolled proliferation of immature lymphocytes. It is the most common type of leukemia for individuals under the age of 19 (Fig. 8-17).
acute myelogenous leukemia (AML) myel/o bone marrow
-genous pertaining to originating from
leuk/o white
-emia blood condition
This rapidly progressive form of leukemia develops from immature bone marrow stem cells.
chronic lymphocytic leukemia (CLL) lymph/o lymph
cyt/o cell
-ic pertaining to
leuk/o white
-emia blood condition
A slowly progressing form of leukemia in which immature lymphocytes proliferate. Occurs most frequently in middle age (or older) adults, rarely in children.
chronic myelogenous leukemia (CML) myel/o bone marrow
-genous pertaining to originating from
leuk/o white
-emia blood condition
A slowly progressing form of leukemia in which immature bone marrow cells proliferate. Like CLL, it occurs most frequently in middle age (or older) adults, rarely in children.
Hodgkin lymphoma lymph/o lymph
-oma tumor, mass
Also termed Hodgkin disease, this cancer is diagnosed by the detection of a type of cell specific only to this disorder: Reed-Sternberg cells.
myeloma, multiple myel/o bone marrow
-oma tumor, mass
Also termed plasma cell dyscrasia or myelomatosis, this rare malignancy of the plasma cells is formed from B lymphocytes. It is called “multiple” myeloma because the tumors are found in many bones. If it occurs in only one bone, the tumor is referred to as a plasmacytoma (Fig. 8-18).
non-Hodgkin lymphoma lymph/o lymph
-oma tumor, mass
A collection of all other lymphatic cancers but Hodgkin lymphomas. This type is the more numerous of the two lymphomas and is the sixth most common type of cancer in the United States.
thymoma, malignant thym/o thymus gland
-oma tumor, mass
Also termed thymic carcinoma, this rare malignancy of the thymus gland is particularly invasive and, unlike its benign form, is not associated with autoimmune disorders.

image

Procedures

Terms Related to Laboratory Tests

Term Word Origin Definition
AIDS tests—ELISA, Western blot   Tests to detect the presence of HIV types 1 and 2 (Fig. 8-19).
basic metabolic panel (BMP)   Group of blood tests to measure calcium; glucose; electrolytes such as sodium (Na), potassium (K), and chloride (Cl); creatinine; and blood urea nitrogen (BUN).
blood cultures   Blood samples are submitted to propagate microorganisms that may be present. Cultures may be indicated for bacteremia or septicemia, or to discover other pathogens (fungi, viruses, or parasites) (Fig. 8-20).
complete blood cell count (CBC)   Twelve tests, including RBC (red blood cell count), WBC (white blood cell count), Hb (hemoglobin), Hct/PCV (hematocrit/packed-cell volume), and diff (WBC differential).
comprehensive metabolic panel (CMP)   Set of 14 blood tests that add protein and liver function tests to the BMP. Glucose is also measured with a different method than in the basic panel.
Coombs antiglobulin test anti- against
-globulin protein substance
Blood test to diagnose hemolytic disease of the newborn (HDN), acquired hemolytic anemia, or a transfusion reaction.
diff count   Measure of the numbers of the different types of WBCs.
erythrocyte sedimentation rate (ESR) erythr/o red
-cyte cell
Measurement of time for mature RBCs to settle out of a blood sample after an anticoagulant is added. An increased ESR indicates inflammation.
hematocrit (Hct), packed-cell volume (PCV) hemat/o blood
-crit separate
Measure of the percentage of RBCs in the blood.
hemoglobin (Hgb, Hb) hem/o blood
-globin protein substance
Measurement of the iron-containing pigment of RBCs that carries oxygen to tissues.
mean corpuscular hemoglobin (MCH) hem/o blood
-globin protein substance
Test to measure the average weight of hemoglobin per RBC. Useful in diagnosing anemia.
mean corpuscular hemoglobin concentration (MCHC)   Test to measure the concentration of hemoglobin in RBCs. This test is useful for measuring a patient’s response to treatment for anemia.
partial thromboplastin time (PTT) thromb/o clot, clotting
-plastin forming substance
Test of blood plasma to detect coagulation defects of the intrinsic system; used to detect hemophilia.
prothrombin time (PT) pro- before
-thrombin clotting substance
Test that measures the amount of time taken for clot formation. It is used to determine the cause of unexplained bleeding, to assess levels of anticoagulation in patients taking warfarin or with vitamin K deficiency, and to assess the ability of the liver to synthesize blood-clotting proteins.
Schilling test   Nuclear medicine test used to diagnose pernicious anemia and other metabolic disorders.
white blood cell count (WBC)   Measurement of the number of leukocytes in the blood. An increase may indicate the presence of an infection; a decrease may be caused by radiation or chemotherapy.

image

Terms Related to Blood and Bone Marrow Procedures

Term Word Origin Definition
apheresis -apheresis removal Temporary removal of blood from a donor, in which one or more components are removed, and the rest of the blood is reinfused into the donor. Examples include leukapheresis, removal of WBCs; plasmapheresis, removal of plasma; and plateletpheresis, removal of thrombocytes. Also called pheresis.
autologous bone marrow transplant auto- self
log/o study
-ous pertaining to
Harvesting of patient’s own healthy bone marrow before treatment for reintroduction later.
autologous transfusion auto- self
log/o study
-ous pertaining to
trans- across
-fusion pouring
Process in which the donor’s own blood is removed and stored in anticipation of a future need.
autotransfusion auto- self
trans- across
-fusion pouring
Process in which the donor is transfused with his/her own blood, after anticoagulation and filtration, from an active bleeding site in cases of major surgery or trauma.
blood transfusion trans- across
-fusion pouring
Intravenous transfer of blood from a donor to a recipient, giving either whole blood or its components (Fig. 8-21).
bone marrow transplant (BMT)   The transplantation of bone marrow to stimulate production of normal blood cells.
hemostasis hem/o blood
stasis stopping, controlling
The control of bleeding by mechanical or chemical means.
homologous bone marrow transplant homo- same (species)
log/o study
-ous pertaining to
Transplantation of healthy bone marrow from a donor to a recipient to stimulate formation of new blood cells.

Terms Related to Lymphatic and Immune System Interventions

Term Word Origin Definition
adenoidectomy adenoid/o adenoid
-ectomy cutting out
Removal of the adenoids (pharyngeal tonsils) (Fig. 8-22).
biopsy (bx) of lymphatic structures bi/o life
-opsy viewing
lymphat/o lymph
-ic pertaining to
Removal of the lymph nodes or lymphoid tissue as a means of diagnosis and treatment.
lymphadenectomy lymphaden/o lymph gland
-ectomy cutting out
Removal of a lymph node.
splenectomy splen/o spleen
-ectomy cutting out
Removal of the spleen.

image

Build the terms.

Pharmacology

Blood Drugs

anticoagulants: Prevent or delay the coagulation of blood and the formation of thrombi. Examples include heparin, warfarin (Coumadin), enoxaparin (Lovenox), and apixaban (Eliquis).

antiplatelets: Inhibit the function of platelets or destroy them. Examples include aspirin, clopidogrel (Plavix), dipyridamole (Persantine), ticlopidine (Ticlid), and abciximab (ReoPro).

blood-flow modifiers: Promote blood flow by keeping platelets from clumping or decreasing blood viscosity. Examples include the prescription medications cilostazol (Pletal) and pentoxifylline (Trental) and the herbal product ginkgo biloba.

colony-stimulating factors (CSFs): Stimulate the production of white blood cells in the bone marrow. The two kinds are granulocyte CSF (G-CSF) and granulocyte-macrophage CSF (GM-CSF). Available synthetic agents of each type are filgrastim (Neupogen) and sargramostim (Leukine), respectively.

erythropoietic agents: Increase production of RBCs by stimulating erythropoiesis. Two available agents are epoetin alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp).

hematinics: Increase the number of erythrocytes and/or hemoglobin concentration in the erythrocytes usually to treat iron-deficiency anemia. Examples are iron supplements and B-complex vitamins.

hematopoietic agents: Stimulate blood cell production. Subdivisions of this class include colony-stimulating factors, erythropoietic agents, and thrombopoietic factors.

hemostatics: Help stop the flow of blood. Examples include aminocaproic acid (Amicar) and tranexamic acid (Cyklokapron).

thrombopoietic factors: Stimulate the production of thrombocytes or platelets. Oprelvekin (Neumega) is an available agent.

Immune Drugs

antineoplastics: Treat cancer by preventing growth or promoting destruction of neoplastic (tumor) cells. Numerous drugs, including methotrexate and rituximab (Rituxan), fall into this category.

antiretrovirals: Minimize the replication of HIV and its progression into AIDS. Examples include zidovudine or AZT (Retrovir) and efavirenz (Sustiva).

corticosteroids: Steroids that suppress the immune system and reduce inflammation. Examples include fluticasone (Flovent, Flonase), hydrocortisone (Cortizone), and prednisone (Rayos).

cytotoxic agents: Damage or destroy cells to treat cancer; often act as immunosuppressants or antineoplastics.

immune modulators: Reduce the impact of immune system disorders. Dimethyl fumarate (Tecfidera) is an example of a drug used to treat multiple sclerosis.

immunosuppressants: Minimize the immune response. Examples include azathioprine (Imuran), cyclophosphamide (Cytoxan), cyclosporine (Sandimmune), and tacrolimus (Prograf).

protease inhibitors: Antiretrovirals used to treat HIV infection. By blocking the production of an essential enzyme called protease, these drugs keep the virus from replicating. Examples are indinavir (Crixivan), nelfinavir (Viracept), and saquinavir (Invirase).

vaccines: Modified disease-causing microbial components administered to induce immunity or reduce the pathological effects of a disease. Examples are the measles, mumps, rubella, and chickenpox vaccine. A vaccination is an injection or oral solution derived from dead or weakened (attenuated) virus.

image

Recognizing Suffixes for PCS

Now that you’ve finished reading about the procedures for the blood, blood-forming organs, and immune mechanisms, take a look at this review of the suffixes used in their terminology. Each of these suffixes is associated with one or more root operations in the medical surgical section or one of the other categories in PCS.

Abbreviations

Abbreviation Meaning
A, B, AB, O blood types
AIDS acquired immunodeficiency syndrome
ALL acute lymphocytic leukemia
ALPS autoimmune lymphoproliferative syndrome
AML acute myelogenous leukemia
basos basophils
BMP basic metabolic panel
BMT bone marrow transplant
BUN blood urea nitrogen
bx biopsy
CBC complete blood cell count
Cl chloride
CLL chronic lymphocytic leukemia
CML chronic myelogenous leukemia
CMP comprehensive metabolic panel
CO2 carbon dioxide
DIC disseminated intravascular coagulopathy
diff differential WBC count
EBV Epstein-Barr virus
eosins eosinophils
ESR erythrocyte sedimentation rate
G6PD glucose-6-phosphate-dehydrogenase
GVHD graft-versus-host disease
Hb, Hgb hemoglobin
Hct hematocrit, packed-cell volume
HDN hemolytic disease of the newborn
HIV human immunodeficiency virus
HSC hematopoietic stem cell
Ig immunoglobulin
K potassium
lymphs lymphocytes
MCH mean corpuscular hemoglobin
MCHC mean corpuscular hemoglobin concentration
Na sodium
neuts neutrophils
NK natural killer cells
PCV packed-cell volume, hematocrit
plats platelets, thrombocytes
PMNs, polys polymorphonucleocytes
PT prothrombin time
PTT partial thromboplastin time
RBC red blood cell (count)
segs segmented neutrophils
SIRS systemic immune response syndrome
stabs band cells
WBC white blood cell (count)